Mirae Asset Global ETFs Holdings’s Adaptive Biotechnologies ADPT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	70,975 +940	+1%	+$14.4K	﹤0.01%	1402
2026 Q1	$972K	Buy	70,035 +660	+1%	+$10.5K	﹤0.01%	1533
2025 Q4	$1.13M	Buy	69,375 +267	+0.4%	+$4.36K	﹤0.01%	1450
2025 Q3	$1.03M	Sell	69,108 -12,795	-16%	-$156K	﹤0.01%	1471
2025 Q2	$954K	Buy	81,903 +13,073	+19%	+$119K	﹤0.01%	1465
2025 Q1	$511K	Buy	68,830 +2,914	+4%	+$22.4K	﹤0.01%	1858
2024 Q4	$395K	Buy	65,916 +2,625	+4%	+$14.5K	﹤0.01%	2041
2024 Q3	$324K	Buy	63,291 +6,346	+11%	+$27.6K	﹤0.01%	2128
2024 Q2	$206K	Buy	+56,945	New	+$181K	﹤0.01%	2234

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ADPT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Adaptive Biotechnologies (ADPT) stake by 1.3% in Q2 2026, buying an estimated $14.4K and bringing the position to 70,975 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

Mirae Asset Global ETFs Holdings first reported a position in ADPT in Q2 2024 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 70,975 shares of Adaptive Biotechnologies worth $1.52M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 940 Adaptive Biotechnologies shares in Q2 2026, an estimated $14.4K.
Adaptive Biotechnologies made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1402 holding.
Mirae Asset Global ETFs Holdings first reported a position in Adaptive Biotechnologies in Q2 2024 and has held it in 9 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.